Cargando...
Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
Tumor immunotherapy is considered to be a highlight in cancer treatment in recent years. Indoleamine 2,3-dioxygenase 1 (IDO1) is closely related to the over expression of many cancers, and is therefore a promising target for tumor immunotherapy. To search for novel IDO1-targeting therapeutic agents,...
Guardado en:
| Publicado en: | Front Pharmacol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7555427/ https://ncbi.nlm.nih.gov/pubmed/33101032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.579024 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|